Evidence map›Paper›PMID 25744000›Full record

ArticleThe British journal of nutrition2015

Synergistic effects of high dietary calcium and exogenous parathyroid hormone in promoting osteoblastic bone formation in mice.

Yuxu Feng, Min Zhou, Qunhu Zhang, Huan Liu, Yong Xu, Lei Shu, Jue Zhang, Dengshun Miao, Yongxin Ren

Open access · hybridAbstract readComparative Study
In one paragraph

Article in The British journal of nutrition, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yuxu FengDepartment of Orthopaedics,The First Affiliated Hospital, Nanjing Medical University,Nanjing, Jiangsu,People's Republic of China.
Min ZhouDepartment of Orthopaedics,The First Affiliated Hospital, Nanjing Medical University,Nanjing, Jiangsu,People's Republic of China.
Qunhu ZhangDepartment of Orthopaedics,The First Affiliated Hospital, Nanjing Medical University,Nanjing, Jiangsu,People's Republic of China.
Huan LiuDepartment of Orthopaedics,The First Affiliated Hospital, Nanjing Medical University,Nanjing, Jiangsu,People's Republic of China.
Yong XuDepartment of Orthopaedics,The First Affiliated Hospital, Nanjing Medical University,Nanjing, Jiangsu,People's Republic of China.
Lei ShuDepartment of Geriatric Endocrinology,Jinling Hospital, Nanjing University School of Medicine,Nanjing,People's Republic of China.
Jue ZhangDepartment of Emergency,The Affiliated Jiangning Hospital of Nanjing Medical University,Nanjing, Jiangsu,People's Republic of China.
Dengshun MiaoCenter for Bone and Stem Cell Research, Nanjing Medical University,Nanjing, Jiangsu,People's Republic of China.
Yongxin RenDepartment of Orthopaedics,The First Affiliated Hospital, Nanjing Medical University,Nanjing, Jiangsu,People's Republic of China.
Nanjing Medical University · CNNanjing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, we investigated whether high dietary Ca and exogenous parathyroid hormone 1-34 fragments (PTH 1-34) have synergistic effects on bone formation in adult mice, and explored the related mechanisms. Adult male mice were fed a normal diet, a high-Ca diet, a PTH-treated diet, or a high-Ca diet combined with subcutaneously injected PTH 1-34 (80 μg/kg per d) for 4 weeks. Bone mineral density, trabecular bone volume, osteoblast number, alkaline phosphatase (ALP)- and type I collagen-positive areas, and the expression levels of osteoblastic bone formation-related genes and proteins were increased significantly in mice fed the high-Ca diet, the PTH-treated diet, and, even more dramatically, the high-Ca diet combined with PTH. Osteoclast number and surface and the ratio of receptor activator for nuclear factor-κB ligand (RANKL):osteoprotegerin (OPG) were decreased in the high-Ca diet treatment group, increased in the PTH treatment group, but not in the combined treatment group. Furthermore, third-passage osteoblasts were treated with high Ca (5 mM), PTH 1-34 (10⁻⁸ M) or high Ca combined with PTH 1-34. Osteoblast viability and ALP activity were increased in either the high Ca-treated or PTH-treated cultures and, even more dramatically, in the cultures treated with high Ca plus PTH, with consistent up-regulation of the expression levels of osteoblast proliferation and differentiation-related genes and proteins. These results indicate that dietary Ca and PTH play synergistic roles in promoting osteoblastic bone formation by stimulating osteoblast proliferation and differentiation.

Indexed as

Food-Drug InteractionsAnimalsBone and BonesBone DensityBone Density Conservation AgentsBone ResorptionCalcium ChannelsCalcium, DietaryCell ProliferationCells, CulturedCombined Modality TherapyMaleMice, Inbred C57BLOsteoblastsOsteogenesisParathyroid HormoneBone Density Conservation AgentsCalcium ChannelsCalcium, DietaryParathyroid HormonePeptide FragmentsReceptors, Calcium-SensingReceptors, Parathyroid HormoneTrpv6 protein, mouseTRPV Cation ChannelsBone formation

Identifiers

PMID25744000
PMCPMC4392706
OpenAlexW2095774481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.